You are here: Home » Companies » News
Business Standard

Strides Shasun gets inspection report from USFDA for Bengaluru facility

The facility supports important current and future products for the US market

Press Trust of India  |  New Delhi 

Strides Shasun
Strides Shasun

Drug firm has received an (EIR) from the US health regulator for its formulations facility at

"The company's formulations facility (KRSG Gardens) in which was inspected by the in May 2017 has received the EIR, thereby confirming the closure of the inspection," Strides said in a BSE filing.


The facility manufactures tablets, capsules, liquids, sachets, creams and ointments. The facility supports important current and future products for the US market.

Shares of were trading at Rs 927.50 apiece, up 2.10 per cent from the previous close on BSE.

First Published: Fri, September 01 2017. 14:16 IST
RECOMMENDED FOR YOU